13C-glucose breath test for evaluation of glucose metabolism in patients with fatty liver

13C-glucose breath test for evaluation of glucose metabolism in patients with fatty liver - 13C-glucose breath test for evaluation of glucose metabolism in patients with fatty liver

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025445

Enrollment

Registered

2017-01-10

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver disease

Interventions

100mg of 13C-glucose + 50mL of water is administerd, thereafter breaths are collected. The frequency of 13C-glucose administration is once.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: fatty liver disease

Exclusion criteria

Exclusion criteria: pregnancy and lactating women

Design outcomes

Primary

Measure	Time frame
13CO2 in breath at the time of breath test.	—

Countries

Japan

Contacts

Public ContactShojiro Sawada

Tohoku Universuty Hospital Dept of Diabetes and Metabolism

ssawada@med.tohoku.ac.jp022-717-7611

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026